Cytosorbents (CTSO) News Today $0.87 +0.03 (+3.55%) Closing price 04:00 PM EasternExtended Trading$0.87 0.00 (0.00%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTSO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period CTSO: CytoSorbents Reports Strong 1st Quarter 2025 ResultsMay 21 at 6:22 PM | finance.yahoo.comCytosorbents FY2025 EPS Forecast Lifted by HC WainwrightCytosorbents Co. (NASDAQ:CTSO - Free Report) - Research analysts at HC Wainwright increased their FY2025 earnings per share estimates for shares of Cytosorbents in a research report issued to clients and investors on Thursday, May 15th. HC Wainwright analyst S. Lee now expects that the medical reMay 21 at 2:41 AM | marketbeat.comFY2025 EPS Estimates for Cytosorbents Raised by AnalystMay 19 at 2:43 AM | americanbankingnews.comCytosorbents (NASDAQ:CTSO) Earns "Buy" Rating from D. Boral CapitalMay 18 at 3:33 AM | americanbankingnews.comCytosorbents' (CTSO) Neutral Rating Reiterated at HC WainwrightMay 18 at 3:01 AM | americanbankingnews.comCytosorbents Corporation (NASDAQ:CTSO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comCytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 16, 2025 | finanznachrichten.deStockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)StockNews.com assumed coverage on shares of Cytosorbents in a report on Tuesday. They set a "hold" rating on the stock.May 15, 2025 | marketbeat.comCytosorbents Corporation (CTSO) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comCytoSorbents Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 14, 2025 | prnewswire.comGranahan Investment Management LLC Sells 890,302 Shares of Cytosorbents Co. (NASDAQ:CTSO)Granahan Investment Management LLC lessened its holdings in Cytosorbents Co. (NASDAQ:CTSO - Free Report) by 42.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,204,580 shares of the medical research company's stock after seMay 13, 2025 | marketbeat.comCytosorbents (CTSO) to Release Earnings on WednesdayMay 12, 2025 | americanbankingnews.comCytosorbents (CTSO) Projected to Post Earnings on WednesdayCytosorbents (NASDAQ:CTSO) will be releasing its Q1 2025 earnings after the market closes on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-cytosorbents-co-stock/)May 9, 2025 | marketbeat.comCTSO: CytoSorbents provides regulatory update for DrugSorb-ATR.May 8, 2025 | msn.comCytosorbents (NASDAQ:CTSO) Coverage Initiated at StockNews.comStockNews.com started coverage on Cytosorbents in a report on Monday. They set a "hold" rating for the company.May 6, 2025 | marketbeat.comCytosorbents' (CTSO) "Buy" Rating Reaffirmed at D. Boral CapitalD. Boral Capital restated a "buy" rating and set a $10.00 price objective on shares of Cytosorbents in a research note on Friday.May 4, 2025 | marketbeat.comDemystifying CytoSorbents: Insights From 4 Analyst ReviewsMay 2, 2025 | benzinga.comCytoSorbents Provides Regulatory Update for DrugSorb-ATRMay 1, 2025 | prnewswire.comCytoSorbents to Report First Quarter 2025 Financial Results and Recent Business HighlightsApril 29, 2025 | prnewswire.comCytoSorbents gets $1.7M from New Jersey business tax certificate transfer programApril 21, 2025 | msn.comCytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer ProgramApril 21, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by StockNews.comStockNews.com started coverage on shares of Cytosorbents in a research report on Saturday. They set a "hold" rating on the stock.April 20, 2025 | marketbeat.comCytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate ControllerApril 17, 2025 | prnewswire.comCytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North AmericaApril 14, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.comStockNews.com began coverage on Cytosorbents in a research note on Friday. They set a "hold" rating for the company.April 13, 2025 | marketbeat.comAnalysts Offer Predictions for Cytosorbents Q1 EarningsCytosorbents Co. (NASDAQ:CTSO - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings estimates for Cytosorbents in a research report issued on Thursday, April 3rd. HC Wainwright analyst S. Lee expects that the medical research company will earn ($0.08) per share forApril 8, 2025 | marketbeat.comBrokers Offer Predictions for Cytosorbents Q1 EarningsCytosorbents Co. (NASDAQ:CTSO - Free Report) - Stock analysts at Zacks Small Cap issued their Q1 2025 earnings estimates for shares of Cytosorbents in a research report issued on Friday, April 4th. Zacks Small Cap analyst T. Kerr anticipates that the medical research company will earn ($0.08) perApril 8, 2025 | marketbeat.comHC Wainwright Predicts Cytosorbents FY2028 EarningsCytosorbents Co. (NASDAQ:CTSO - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for Cytosorbents in a research report issued on Thursday, April 3rd. HC Wainwright analyst S. Lee expects that the medical research company will earn ($0.07) per share for the year.April 6, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Given "Neutral" Rating at HC WainwrightHC Wainwright reaffirmed a "neutral" rating and issued a $1.00 target price on shares of Cytosorbents in a research note on Thursday.April 5, 2025 | marketbeat.comCTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.April 4, 2025 | finance.yahoo.comCytoSorbents Extends Expiration Date of Outstanding Series B Right WarrantsApril 4, 2025 | prnewswire.comCytosorbents' (CTSO) Buy Rating Reiterated at D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and issued a $10.00 price objective on shares of Cytosorbents in a research report on Tuesday.April 2, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPSCytosorbents (NASDAQ:CTSO - Get Free Report) issued its quarterly earnings results on Monday. The medical research company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.04. Cytosorbents had a negative net margin of 49.47% and a negative return on equity of 118.54%.April 1, 2025 | marketbeat.comCytoSorbents reports Q4 adjusted EPS (3c) vs. (17c) last yearApril 1, 2025 | markets.businessinsider.comCytosorbents Corporation (NASDAQ:CTSO) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comCytosorbents Corporation (CTSO) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comCytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsMarch 31, 2025 | prnewswire.comCytosorbents FY Earnings PreviewMarch 29, 2025 | msn.com1CTSO : Insights into CytoSorbents's Upcoming EarningsMarch 29, 2025 | benzinga.comCytosorbents (CTSO) Expected to Announce Quarterly Earnings on MondayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Monday, March 31, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=670228)March 24, 2025 | marketbeat.comCytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual AuditMarch 21, 2025 | prnewswire.comCytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average - Here's WhyCytosorbents (NASDAQ:CTSO) Stock Price Passes Above Two Hundred Day Moving Average - Here's WhyMarch 18, 2025 | marketbeat.comCytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years agoMarch 10, 2025 | uk.finance.yahoo.comCytoSorbents reiterates Q4 product revenue view $9M-$9.2MMarch 4, 2025 | markets.businessinsider.comCytoSorbents postpones earnings release to allow time for annual auditMarch 4, 2025 | markets.businessinsider.comCytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate ControllerMarch 4, 2025 | globenewswire.comCytosorbents Corp. CTSO (U.S.: Nasdaq)February 27, 2025 | wsj.comCytosorbents (CTSO) to Release Quarterly Earnings on ThursdayCytosorbents (NASDAQ:CTSO) will be releasing earnings after the market closes on Thursday, March 6, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=670228)February 27, 2025 | marketbeat.comCytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business HighlightsFebruary 27, 2025 | finance.yahoo.comCytosorbents (NASDAQ:CTSO) Given Buy Rating at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and issued a $10.00 price objective on shares of Cytosorbents in a research note on Tuesday.February 25, 2025 | marketbeat.com Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address CTSO Media Mentions By Week CTSO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CTSO News Sentiment▼0.600.65▲Average Medical News Sentiment CTSO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CTSO Articles This Week▼142▲CTSO Articles Average Week Get Cytosorbents News Delivered to You Automatically Sign up to receive the latest news and ratings for CTSO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SKIN News Today CATX News Today BWAY News Today LAKE News Today ELMD News Today CVRX News Today RCEL News Today SGHT News Today TLSI News Today LNSR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CTSO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytosorbents With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTSO Stock Free CTSO Stock Alerts